v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Total Palantir’s Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss), Net
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     2,338,795,000          
Beginning balance at Dec. 31, 2024 $ 5,094,407 $ 5,003,275 $ 2,339 $ 10,193,970 $ (5,611) $ (5,187,423)   $ 91,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     19,102,000          
Issuance of common stock from the exercise of stock options 95,201 95,201 $ 19 95,182        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     14,325,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 14 (14)        
Repurchases of common stock (in shares)     (375,000)          
Repurchases of common stock (36,594) (36,594) $ 0 (36,594)        
Stock-based compensation 315,929 315,929   315,929        
Other comprehensive loss (income) 10,332 10,332     10,332   $ 0  
Net income 546,289 540,758       540,758   5,531
Ending balance (in shares) at Jun. 30, 2025     2,371,847,000          
Ending balance at Jun. 30, 2025 6,025,564 5,928,901 $ 2,372 10,568,473 4,721 (4,646,665)   96,663
Beginning balance (in shares) at Mar. 31, 2025     2,359,663,000          
Beginning balance at Mar. 31, 2025 5,518,973 5,424,155 $ 2,360 10,398,181 (2,994) (4,973,392)   94,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     5,528,000          
Issuance of common stock from the exercise of stock options 28,617 28,617 $ 5 28,612        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     6,820,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 7 (7)        
Repurchases of common stock (in shares)     (164,000)          
Repurchases of common stock (18,596) (18,596) $ 0 (18,596)        
Stock-based compensation 160,283 160,283   160,283        
Other comprehensive loss (income) 7,715 7,715     7,715   $ 0  
Net income 328,572 326,727       326,727   1,845
Ending balance (in shares) at Jun. 30, 2025     2,371,847,000          
Ending balance at Jun. 30, 2025 $ 6,025,564 5,928,901 $ 2,372 10,568,473 4,721 (4,646,665)   96,663
Beginning balance (in shares) at Dec. 31, 2025 2,391,192,000   2,391,192,000          
Beginning balance at Dec. 31, 2025 $ 7,488,011 7,387,268 $ 2,391 10,933,325 13,942 (3,562,390)   100,743
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares) 2,067,000   2,067,000          
Issuance of common stock from the exercise of stock options $ 9,757 9,757 $ 2 9,755        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     9,646,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 10 (10)        
Repurchases of common stock (in shares)     (8,000)          
Repurchases of common stock (1,500) (1,500) $ 0 (1,500)        
Stock-based compensation 467,297 467,297   467,297        
Other comprehensive loss (income) (21,045) (21,045)     (21,045)      
Net income $ 1,942,364 1,932,417       1,932,417   9,947
Ending balance (in shares) at Jun. 30, 2026 2,402,897,000   2,402,897,000          
Ending balance at Jun. 30, 2026 $ 9,884,884 9,774,194 $ 2,403 11,408,867 (7,103) (1,629,973)   110,690
Beginning balance (in shares) at Mar. 31, 2026     2,397,133,000          
Beginning balance at Mar. 31, 2026 8,556,281 8,449,663 $ 2,397 11,138,528 601 (2,691,863)   106,618
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     1,029,000          
Issuance of common stock from the exercise of stock options 4,858 4,858 $ 1 4,857        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     4,735,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 5 (5)        
Stock-based compensation 265,487 265,487   265,487        
Other comprehensive loss (income) (7,704) (7,704)     (7,704)      
Net income $ 1,065,962 1,061,890       1,061,890   4,072
Ending balance (in shares) at Jun. 30, 2026 2,402,897,000   2,402,897,000          
Ending balance at Jun. 30, 2026 $ 9,884,884 $ 9,774,194 $ 2,403 $ 11,408,867 $ (7,103) $ (1,629,973)   $ 110,690